CSTA
Cystatin-A
Also known as: CYTA_HUMAN, STF1, STFA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01040
- Gene
- CSTA
- Ensembl
- ENSG00000121552
- Chromosome
- 3
- Canonical length
- 98 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins, and kininogens. This gene encodes a stefin that functions as a cysteine protease inhibitor, forming tight complexes with papain and the cathepsins B, H, and L. The protein is one of the precursor proteins of cornified cell envelope in keratinocytes and plays a role in epidermal development and maintenance. Stefins have been proposed as prognostic and diagnostic tools for cancer. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
98 residues, UniProt reviewed canonical sequence.
>P01040|CSTA
1 MIPGGLSEAK PATPEIQEIV DKVKPQLEEK TNETYGKLEA VQYKTQVVAG TNYYIKVRAG
61 DNKYMHLKVF KSLPGQNEDL VLTGYQVDKN KDDELTGFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSTA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 5,787 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 5,787 nTPM
- vagina: 1,836 nTPM
- cervix: 1,354 nTPM
- salivary gland: 890 nTPM
- tonsil: 881 nTPM
- skin: 348 nTPM
Single-cell type
- esophageal apical cells: 161,500 nCPM
- esophageal suprabasal cells: 49,103 nCPM
- suprabasal keratinocytes: 6,579 nCPM
- esophageal basal cells: 3,506 nCPM
- submucosal glandular cells: 421 nCPM
- syncytiotrophoblasts: 412 nCPM
Immune cell
- classical monocyte: 516 nTPM
- myeloid DC: 384 nTPM
- total PBMC: 283 nTPM
- intermediate monocyte: 270 nTPM
- neutrophil: 247 nTPM
- non-classical monocyte: 163 nTPM
Brain region
- white matter: 1.6 nTPM
- medulla oblongata: 1.5 nTPM
- thalamus: 1.5 nTPM
- choroid plexus: 1.3 nTPM
- pons: 0.9 nTPM
- cerebral cortex: 0.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CSTA.
Disease | AllUniProt
Conditions CSTA is implicated in, by any mechanism.
- Peeling skin syndrome 4 (PSS4) MIM:607936
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 31 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Peeling skin syndrome 4
- CSTA-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell adhesion
- keratinocyte differentiation
- negative regulation of proteolysis
- peptide cross-linking
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CSTA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSTA as an antibody target. Whether an autoantibody or antibody against CSTA could matter depends on whether native CSTA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSTA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSTA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...